RESEARCH-USE BIOSIMILAR ANTIBODY
Losatuxizumab
Antibody-drug conjugate · IgG1
Losatuxizumab is an anti-EGFR monoclonal antibody. Losatuxizumab binds to EGFR with EC50s of 0.96 nM for EGFR wild-type, 0.09 nM for EGFRC271A,C283A, 0.12 nM for EGFRvIII, 0.66 nM for EGFR1-501. Losatuxizumab can be used for research of EGFR-expressing cancers.
TARGETEGFR
YAntibody-drug conjugate
CATALOGSC-BS-404
CATALOG NUMBERSC-BS-404
MOLECULAR WEIGHTApprox. 144.8 kDa
PRODUCT FORMATAntibody-drug conjugate
PRODUCT OVERVIEW
A research-use configuration for comparative antibody studies
Losatuxizumab is an anti-EGFR monoclonal antibody. Losatuxizumab binds to EGFR with EC50s of 0.96 nM for EGFR wild-type, 0.09 nM for EGFRC271A,C283A, 0.12 nM for EGFRvIII, 0.66 nM for EGFR1-501. Losatuxizumab can be used for research of EGFR-expressing cancers.
Losatuxizumab is a recombinant research-use antibody directed against EGFR.